ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Agilent Showcases ‘Consistent, Greener, Smarter’ Approach at Analytica 2022

Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its latest workflows and solutions at Analytica 2022, being held 21 to 24 June 2022 in Munich, Germany.

“We are delighted to be back in person at Analytica to meet our customers face to face,” said Maria Angeles Diaz, vice president and general manager of EMEA and India sales at Agilent. “We are eager to have the opportunity to highlight recent technological innovations, including new mass spectrometry products launched at the beginning of June. These intelligent mass spectrometry instruments incorporate artificial intelligence and machine learning capabilities to enhance lab productivity. They also all carry the My Green Lab Accountability, Consistency, Transparency (ACT) label.”

At Analytica 2022, Agilent will highlight recent launches, including:

  • 5977C GC/MSD: the latest in trusted single quadrupole GC/MS instruments along with the new HydroInert source to explore hydrogen as a viable alternative to helium as a carrier gas for GC/MS
  • 7000E and 7010C Triple Quadrupole GC/MS: representing the latest iterations in Agilent GC/MS products, providing optimal operational efficiency for high-throughput labs
  • InfinityLab Bio LC portfolio: a range of fully biocompatible and bio-inert LC systems and solutions, including the recently released Bio 2D-LC, that enable robust, accurate bioanalysis from drug discovery and development to QA/QC
  • Agilent XF Pro Analyzer: featuring new pharma-oriented workflow solutions that incorporate advanced experimental design and analysis tools

Agilent can be found in Hall A2, Booth 201 showcasing all its innovations from lab informatics to chromatography, mass spectrometry, and atomic, Raman, and molecular spectroscopy.

Agilent will also have a Cell Analysis booth at 201A in Hall A3, dedicated to the full range of cell analysis offerings. The booth will include the Seahorse XF Pro Analyzer, BioTek Cytation C10, BioStack microplate stacker, AssayMAP Bravo platform, and an array of microplates.

Technical experts will be available at both booths to provide information regarding the latest Agilent innovations and portfolio of intuitive workflows and solutions.

Agilent will also host a series of forum talks throughout the week at Analytica in the Biotech Forum, Analytica Forum, and Forum Digital Transformation. Please click here for more information.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Catherine Kaye

European PR Manager

Agilent Technologies

T: 07775 410632

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.